{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:19:51Z","timestamp":1786119591904,"version":"build-2736575974"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,4]]},"DOI":"10.1097\/aog.0b013e31816a2476","type":"journal-article","created":{"date-parts":[[2010,11,30]],"date-time":"2010-11-30T07:36:13Z","timestamp":1291102573000},"page":"857-864","source":"Crossref","is-referenced-by-count":64,"title":["Effects of Third-Generation Oral Contraceptives on High-Sensitivity C-reactive Protein and Homocysteine in Young Women"],"prefix":"10.1097","volume":"111","author":[{"given":"Sabina","family":"Cauci","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Di Santolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer F.","family":"Culhane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuliana","family":"Stel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Gonano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Secondo","family":"Guaschino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-9-20210126","doi-asserted-by":"crossref","first-page":"2818","DOI":"10.1161\/01.CIR.0000132467.45278.59","article-title":"Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?","volume":"109","author":"Ridker","year":"2004","journal-title":"Circulation"},{"key":"R2-9-20210126","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1373\/clinchem.2006.083881","article-title":"Homocysteine, 5,10-methylenetetrahydrofolate reductase 677C>T polymorphism, nutrient intake, and incident cardiovascular disease in 24,968 initially healthy women.","volume":"53","author":"Zee","year":"2007","journal-title":"Clin Chem"},{"key":"R3-9-20210126","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/01.CIR.100.7.713","article-title":"Hormone replacement therapy and increased plasma concentration of C-reactive protein.","volume":"100","author":"Ridker","year":"1999","journal-title":"Circulation"},{"key":"R4-9-20210126","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1056\/NEJM200003233421202","article-title":"C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women.","volume":"342","author":"Ridker","year":"2000","journal-title":"N Engl J Med"},{"key":"R5-9-20210126","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1373\/clinchem.2003.021634","article-title":"Facts and recommendations about total homocysteine determinations: an expert opinion.","volume":"50","author":"Refsum","year":"2004","journal-title":"Clin Chem"},{"key":"R6-9-20210126","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1016\/S0140-6736(97)02358-1","article-title":"Acute myocardial infarction and combined oral contraceptives: results of an international multicentre case-control study. WHO Collaborative Study of Cardiovascular Disease and Steroid Hormone Contraception.","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"R7-9-20210126","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1056\/NEJMoa003216","article-title":"Oral contraceptives and the risk of myocardial infarction.","volume":"345","author":"Tanis","year":"2001","journal-title":"N Engl J Med"},{"key":"R8-9-20210126","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/01.AOG.0000255819.10187.70","article-title":"Venous thromboembolism in obstetrics and gynecology.","volume":"109","author":"Krivak","year":"2007","journal-title":"Obstet Gynecol"},{"key":"R9-9-20210126","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1056\/NEJM199011153232003","article-title":"The effects of different formulations of oral contraceptive agents on lipid and carbohydrate metabolism.","volume":"323","author":"Godsland","year":"1990","journal-title":"N Engl J Med"},{"key":"R10-9-20210126","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1182\/blood-2003-04-1285","article-title":"Effect of second- and third-generation oral contraceptives on the protein C system in the absence or presence of the factor VLeiden mutation: a randomized trial.","volume":"103","author":"Kemmeren","year":"2004","journal-title":"Blood"},{"key":"R11-9-20210126","first-page":"488","article-title":"Hormone therapy and thromboembolic disease.","volume":"14","author":"Battaglioli","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"R12-9-20210126","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: Use of hormonal contraception in women with coexisting medical conditions.","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"key":"R13-9-20210126","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.ajog.2007.03.031","article-title":"A randomized trial of the intrauterine contraceptive device vs hormonal contraception in women who are infected with the human immunodeficiency virus.","volume":"197","author":"Stringer","year":"2007","journal-title":"Am J Obstet Gynecol"},{"key":"R14-9-20210126","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1161\/01.CIR.98.8.731","article-title":"Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women.","volume":"98","author":"Ridker","year":"1998","journal-title":"Circulation"},{"key":"R15-9-20210126","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1373\/49.4.611","article-title":"Standardization of immunoassays for measurement of high-sensitivity C-reactive protein. Phase I: evaluation of secondary reference materials.","volume":"49","author":"Kimberly","year":"2003","journal-title":"Clin Chem"},{"key":"R16-9-20210126","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association.","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"R17-9-20210126","doi-asserted-by":"crossref","first-page":"21","DOI":"10.7326\/0003-4819-145-1-200607040-00128","article-title":"The effect of including C-reactive protein in cardiovascular risk prediction models for women.","volume":"145","author":"Cook","year":"2006","journal-title":"Ann Intern Med"},{"key":"R18-9-20210126","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/01.CIR.0000112581.96154.EA","article-title":"Serum homocysteine in relation to mortality and morbidity from coronary heart disease: a 24-year follow-up of the population study of women in Gothenburg.","volume":"109","author":"Zylberstein","year":"2004","journal-title":"Circulation"},{"key":"R19-9-20210126","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1538-7836.2004.00508.x","article-title":"Folate, homocysteine levels, methylenetetrahydrofolate reductase (MTHFR) 677C\u2013>T variant, and the risk of myocardial infarction in young women: effect of female hormones on homocysteine levels.","volume":"2","author":"Tanis","year":"2004","journal-title":"J Thromb Haemost"},{"key":"R20-9-20210126","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1373\/clinchem.2004.043828","article-title":"Effects of oral contraceptives and hormone replacement therapy on markers of cobalamin status.","volume":"51","author":"Riedel","year":"2005","journal-title":"Clin Chem"},{"key":"R21-9-20210126","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.contraception.2005.09.011","article-title":"Effects of two different oral contraceptives on homocysteine metabolism in women with polycystic ovary syndrome.","volume":"73","author":"Cagnacci","year":"2006","journal-title":"Contraception"},{"key":"R22-9-20210126","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.contraception.2007.04.016","article-title":"Evaluation of iron deficiency in young women in relation to oral contraceptive use.","volume":"76","author":"Casabellata","year":"2007","journal-title":"Contraception"},{"key":"R23-9-20210126","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1161\/01.CIR.0000055014.62083.05","article-title":"C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women.","volume":"107","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"R24-9-20210126","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1001\/jama.295.12.1412","article-title":"Association of physical activity and body mass index with novel and traditional cardiovascular biomarkers in women.","volume":"295","author":"Mora","year":"2006","journal-title":"JAMA"},{"key":"R25-9-20210126","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1016\/j.ahj.2005.02.002","article-title":"Global inflammation predicts cardiovascular risk in women: a report from the Women\u2019s Ischemia Syndrome Evaluation (WISE) study.","volume":"150","author":"Kip","year":"2005","journal-title":"Am Heart J"},{"key":"R26-9-20210126","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1016\/j.ahj.2006.02.015","article-title":"Gender and C-reactive protein: data from the Multiethnic Study of Atherosclerosis (MESA) cohort.","volume":"152","author":"Lakoski","year":"2006","journal-title":"Am Heart J"},{"key":"R27-9-20210126","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2796.2005.01563.x","article-title":"Distribution and determinants of serum high-sensitive C-reactive protein in a population of young adults: The Cardiovascular Risk in Young Finns Study.","volume":"258","author":"Raitakari","year":"2005","journal-title":"J Intern Med"},{"key":"R28-9-20210126","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1373\/clinchem.2006.067181","article-title":"Inflammation and changes in metabolic syndrome abnormalities in US adolescents: findings from the 1988\u20131994 and 1999\u20132000 National Health and Nutrition Examination Surveys.","volume":"52","author":"de Ferranti","year":"2006","journal-title":"Clin Chem"},{"key":"R29-9-20210126","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.atherosclerosis.2003.10.005","article-title":"Third generation oral contraceptive use and cardiovascular risk factors.","volume":"172","author":"D\u00f6ring","year":"2004","journal-title":"Atherosclerosis"},{"key":"R30-9-20210126","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/j.1538-7836.2005.01690.x","article-title":"Treatment with combined oral contraceptives induces a rise in serum C-reactive protein in the absence of a general inflammatory response.","volume":"4","author":"van Rooijen","year":"2006","journal-title":"J Thromb Haemost"},{"key":"R31-9-20210126","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ijcard.2005.06.052","article-title":"Effects of synthetic progestagens on autonomic tone, neurohormones and C-reactive protein levels in young healthy females in reproductive age.","volume":"111","author":"Schueller","year":"2006","journal-title":"Int J Cardiol"},{"key":"R32-9-20210126","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S1537-1891(02)00304-X","article-title":"Pro-inflammatory effects of oestrogens during use of oral contraceptives and hormone replacement treatment.","volume":"39","author":"Kluft","year":"2002","journal-title":"Vascul Pharmacol"},{"key":"R33-9-20210126","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.thromres.2003.11.007","article-title":"Blood levels of homocysteine, folate, vitamin B6 and B12 in women using oral contraceptives compared to non-users.","volume":"112","author":"Lussana","year":"2003","journal-title":"Thromb Res"},{"key":"R34-9-20210126","doi-asserted-by":"crossref","first-page":"S343","DOI":"10.1016\/S0002-9378(99)70694-0","article-title":"Benefits and risks of oral contraceptives.","volume":"180","author":"Sherif","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R35-9-20210126","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1093\/ije\/dyl163","article-title":"Social disadvantage and cardiovascular disease: development of an index and analysis of age, sex, and ethnicity effects.","volume":"35","author":"Anand","year":"2006","journal-title":"Int J Epidemiol"},{"key":"R36-9-20210126","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1111\/j.1468-2982.2007.01324.x","article-title":"Increased C-reactive protein in young adult patients with migraine.","volume":"27","author":"Vanmolkot","year":"2007","journal-title":"Cephalalgia"}],"container-title":["Obstetrics & Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006250-200804000-00009","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:39:54Z","timestamp":1786041594000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006250-200804000-00009"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/aog.0b013e31816a2476","relation":{},"ISSN":["0029-7844"],"issn-type":[{"value":"0029-7844","type":"print"}],"subject":[],"published":{"date-parts":[[2008,4]]}}}